These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30716529)

  • 1. Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.
    Castellana S; Mastroianno S; Palumbo P; Palumbo O; Biagini T; Leone MP; De Luca G; Potenza DR; Amico CM; Mazza T; Russo A; Di Stolfo G; Carella M
    J Electrocardiol; 2019; 53():95-99. PubMed ID: 30716529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.
    Christiaans I; Lekanne dit Deprez RH; van Langen IM; Wilde AA
    Heart Rhythm; 2009 Sep; 6(9):1366-9. PubMed ID: 19539541
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertrophic cardiomyopathy: never-ending complexity].
    Navarro-López F
    Rev Esp Cardiol; 2006 Oct; 59(10):994-6. PubMed ID: 17125707
    [No Abstract]   [Full Text] [Related]  

  • 6. Young and early-onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations.
    Zhao T; Ma Y; Zhang Z; Xian J; Geng X; Wang F; Huang J; Yang Z; Luo Y; Lin Y
    Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12840. PubMed ID: 33949037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].
    Laredo R; Monserrat L; Hermida-Prieto M; Fernández X; Rodríguez I; Cazón L; Alvariño I; Dumont C; Piñón P; Peteiro J; Bouzas B; Castro-Beiras A
    Rev Esp Cardiol; 2006 Oct; 59(10):1008-18. PubMed ID: 17125710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.
    Bhuiyan ZA; Jongbloed JD; van der Smagt J; Lombardi PM; Wiesfeld AC; Nelen M; Schouten M; Jongbloed R; Cox MG; van Wolferen M; Rodriguez LM; van Gelder IC; Bikker H; Suurmeijer AJ; van den Berg MP; Mannens MM; Hauer RN; Wilde AA; van Tintelen JP
    Circ Cardiovasc Genet; 2009 Oct; 2(5):418-27. PubMed ID: 20031616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
    Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.
    Fananapazir L; Epstein ND
    Circulation; 1994 Jan; 89(1):22-32. PubMed ID: 8281650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.
    Marian AJ
    Clin Cardiol; 1995 Apr; 18(4):189-98. PubMed ID: 7788945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign?
    Semsarian C; Yu B; Ryce C; Lawrence C; Washington H; Trent RJ
    Pathology; 1997 Aug; 29(3):305-8. PubMed ID: 9271024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death in young competitive athletes due to genetic cardiac abnormalities.
    Wever-Pinzon OE; Myerson M; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():17-23. PubMed ID: 20089483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Cardiol Rev; 2002; 10(3):173-81. PubMed ID: 12047795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the beta-myosin heavy chain gene and cardiac arrest in childhood. A case report and family study.
    Döhlemann C; Hebe J; Meitinger T; Vosberg HP
    Z Kardiol; 2000 Jul; 89(7):612-9. PubMed ID: 10957787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.